Shiv Kumar Agarwal - Concepedia

Author

Shiv Kumar Agarwal

University of Arkansas for Medical Sciences ORCID

Also Known As

Dr. Shiv Kumar Agarwal, S Agarwal, S. Agarwal, S. K. AGARWAL, S. K. Agarwal, S.K. Agarwal, SHIV KUMAR AGARWAL, Shalabh Agarwal, Shiv Agarwal, Shiv K Agarwal

154

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University of Arkansas for Medical Sciences Icahn School of Medicine at Mount Sinai Central Arkansas Veterans Healthcare System Vanderbilt University Medical Center St. Luke's-Roosevelt Hospital Center

About

Shiv Kumar Agarwal is an author at University of Arkansas for Medical Sciences specializing in medicine, organic chemistry, and chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	897
2	Natural Sciences	8	8	470
3	Engineering	6	6	281
4	Public Health	4	4	187
5	Health Sciences	3	3	68

Shiv Kumar Agarwal

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes Shiv Kumar Agarwal, Srikanth Kasula, Zubair Ahmed, JACC: Cardiovascular Interventions Enhanced RecoveryHeart FailureCardiovascular DiseaseMedicineAcute Care	2016	203
Covalent nucleoside adducts of benzo[a]pyrene 7,8-diol 9,10-epoxides: structural reinvestigation and characterization of a novel adenosine adduct on the ribose moiety Jane M. Sayer, Anju Chadha, Shiv Kumar Agarwal, The Journal of Organic Chemistry Covalent Nucleoside AdductsEngineeringBiochemistryRibose MoietyNatural Sciences	1991	130
Optically active benzo[c]phenanthrene diol epoxides bind extensively to adenine in DNA Anthony Dipple, Margaret A. Pigott, Shiv Kumar Agarwal, Nature Nucleic Acid ChemistryBioorganic ChemistryBiochemistryPhotochemistryNatural Sciences	1987	114
Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity Gurvinder Singh, Anu Singh, Aji Abraham, Journal of Ethnopharmacology InflammationAnti-inflammatoryMedicineTerminalia ArjunaCardiovascular Pharmacology	2008	113
Hyperglycaemia as a predictor of outcome during non-invasive ventilation in decompensated COPD B Chakrabarti, Robert Angus, Shiv Kumar Agarwal, Thorax	2009	96
Chemical characterization of DNA adducts derived from the configurationally isomeric benzo[c]phenanthrene-3,4-diol 1,2-epoxides Shiv Kumar Agarwal, Jane M. Sayer, Herman J. C. Yeh, Journal of the American Chemical Society Molecular CharacterizationMolecular SciencesDnaEngineeringBiochemistry	1987	88
Wearable technology to improve education and patient outcomes in a cardiology fellowship program - a feasibility study Srikanth Vallurupalli, Hakan Paydak, Shiv Kumar Agarwal, Health and Technology Wearable SystemDevice TherapyHealth PolicyRemote Patient MonitoringMedical Technology	2013	75
Potent 1,3-Disubstituted-9<i>H</i>-pyrido[3,4-<i>b</i>]indoles as New Lead Compounds in Antifilarial Chemotherapy<sup>,</sup> Sanjay K. Srivastava, Alka Agarwal, Prem M. S. Chauhan, Journal of Medicinal Chemistry	1999	60
Reactivity and Tumorigenicity of Bay-Region Diol Epoxides Derived from Polycyclic Aromatic Hydrocarbons D. M. JERINA, Jane M. Sayer, Shiv Kumar Agarwal, Advances in experimental medicine and biology DerivativesOrganic ChemistryPolycyclic Aromatic HydrocarbonsChemistryHeterocycle Chemistry	1986	59
Anticancer and anti-inflammatory activities of 1,8-naphthyridine-3-carboxamide derivatives Sanjay K. Srivastava, Manu Jaggi, Anu Singh, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBioorganic Chemistry1,8-Naphthyridine-3-carboxamide DerivativesMedicineNatural Sciences	2007	54

Page 1